FDA's Radiological Health Unit Sets Its FY2017 Regulatory Science Priorities

News The CDRH regulatory science priorities serve as a catalyst to improving the safety, effectiveness, performance and quality of medical devices and radiation-emitting products and to facilitate introducing innovative medical devices into the marketplace. Contributed Author:  U.S. Food and Drug Administration Topics:  Oncology